文献速递间质性肺疾病

围产期低氧诱导因子稳定化可保护实验性支气管肺发育不良的肺泡与血管发育

Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该研究在大鼠绒毛膜羊膜炎诱导的支气管肺发育不良(BPD)模型中,探讨产前或产后给予脯氨酰羟化酶抑制剂(PHi)能否增加肺HIF表达、保护肺结构与功能并预防肺动脉高压。结果显示产前PHi治疗可保护肺泡和血管发育、维持肺功能并预防右心室肥厚,且上调HIF-1a、HIF-2a、VEGF和eNOS表达。

要点

  • 产前PHi治疗可保护宫内内毒素暴露后的肺泡与血管发育及肺功能。
  • 产前PHi治疗可预防右心室肥厚并上调肺HIF-1a、HIF-2a、VEGF和eNOS。
  • 产前或产后PHi治疗可能成为预防产前炎症所致BPD的新策略。

核心结论

  • HIF增强可改善产前内毒素暴露后的肺结构与功能、预防右心室肥厚并改善胎盘结构。

研究设计与样本

  • 研究为大鼠实验性BPD模型,于胚胎第20天经羊膜腔注射内毒素,胚胎第22天剖宫产分娩。
  • 选择性PHi药物二甲氧基甘氨酸或GSK360A于胚胎第20天经羊膜腔或出生后经腹腔注射2周给药。

主要发现

  • 产前PHi治疗可保护宫内内毒素暴露后的肺泡和血管发育、肺功能并预防右心室肥厚。
  • 产前给予PHi可显著上调内毒素暴露后肺HIF-1a、HIF-2a、VEGF和eNOS表达。
  • 出生时收集胎盘和肺组织进行形态学及Western blot检测HIF-1a、HIF-2a、VEGF和eNOS蛋白含量。
  • 第14天评估肺功能,并取组织通过径向肺泡计数确定肺泡化、肺血管密度和右心室肥厚。

临床怎么用

  • 产前或产后PHi治疗可能为预防产前炎症所致BPD提供新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Antenatal inflammation with placental dysfunction is strongly associated with high bronchopulmonary dysplasia (BPD) risk in preterm infants. Whether antenatal or postnatal HIF (hypoxia-inducible factor) augmentation can preserve lung structure and function and prevent pulmonary hypertension after intrauterine inflammation is controversial.Objectives: To determine whether antenatal or postnatal prolyl-hydroxylase inhibitor (PHi) therapy increases lung HIF expression, preserves lung growth and function, and prevents pulmonary hypertension in a rat model of chorioamnionitis-induced BPD caused by antenatal inflammation.Methods: Endotoxin (ETX) was administered to pregnant rats by intraamniotic injection at Embryonic Day 20, and pups were delivered by cesarean section at Embryonic Day 22. Selective PHi drugs, dimethyloxalylglycine or GSK360A, were administered into the amniotic space at Embryonic Day 20 or after birth by intraperitoneal injection for 2 weeks. Placentas and lung tissue were collected at birth for morphometric and Western blot measurements of HIF-1a, HIF-2a, VEGF (vascular endothelial growth factor), and eNOS (endothelial nitric oxide synthase) protein contents. At Day 14, lung function was assessed, and tissues were harvested to determine alveolarization by radial alveolar counts, pulmonary vessel density, and right ventricle hypertrophy (RVH).Measurements and Main Results: Antenatal PHi therapy preserves lung alveolar and vascular growth and lung function and prevents RVH after intrauterine ETX exposure. Antenatal administration of PHi markedly upregulates lung HIF-1a, HIF-2a, VEGF, and eNOS expression after ETX exposure.Conclusions: HIF augmentation improves lung structure and function, prevents RVH, and improves placental structure following antenatal ETX exposure. We speculate that antenatal or postnatal PHi therapy may provide novel strategies to prevent BPD due to antenatal inflammation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Hirsch K, Taglauer E, Seedorf G, et al. Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2020. PMID: 32551816. doi:10.1164/rccm.202003-0601OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。